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Abstract
Background: In this study we aimed to identify and review publications relating to the diagnosis
of joint hypermobility and instability and develop an evidence based approach to the diagnosis of
children presenting with joint hypermobility and related symptoms.
Methods:  We searched Medline for papers with an emphasis on the diagnosis of joint
hypermobility, including Heritable Disorders of Connective Tissue (HDCT).
Results: 3330 papers were identified: 1534 pertained to instability of a particular joint; 1666
related to the diagnosis of Ehlers Danlos syndromes and 330 related to joint hypermobility.
There are inconsistencies in the literature on joint hypermobility and how it relates to and overlaps
with milder forms of HDCT. There is no reliable method of differentiating between Joint
Hypermobility Syndrome, familial articular hypermobility and Ehlers-Danlos syndrome
(hypermobile type), suggesting these three disorders may be different manifestations of the same
spectrum of disorders. We describe our approach to children presenting with joint hypermobility
and the published evidence and expert opinion on which this is based.
Conclusion: There is value in identifying both the underlying genetic cause of joint hypermobility
in an individual child and those hypermobile children who have symptoms such as pain and fatigue
and might benefit from multidisciplinary rehabilitation management.
Every effort should be made to diagnose the underlying disorder responsible for joint hypermobility 
which may only become apparent over time. We recommend that the term "Joint Hypermobility 
Syndrome" is used for children with symptomatic joint hypermobility resulting from any underlying 
HDCT and that these children are best described using both the term Joint Hypermobility 
Syndrome and their HDCT diagnosis.
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Background
In this review we aimed to identify the current literature
pertaining to the diagnosis of children with joint hyper-
mobility. The focus is on clinical signs or investigations
which reliably allow children with a Heritable Disorder of
Connective Tissue (HDCT) and mild musculoskeletal
impairment to be distinguished from children who fall
within the normal spectrum of joint mobility.
Joint hypermobility is common in childhood, occurring
in 8–39% of school age children[1-4]. Prevalence depends
on age, sex and ethnicity and decreases with increasing
age. Girls are generally more hypermobile than boys and
children from Asian backgrounds are generally more
hypermobile than Caucasian children[5]
There is debate in the literature as to whether isolated
joint hypermobility represents the end of the normal
spectrum of joint range of movement or whether it repre-
sents a polygenic group at the mild end of the spectrum of
Heritable Disorders of Connective Tissue[6,7]. It is gener-
ally accepted that the phenomenon runs in families and
tends to be dominantly inherited. The diagnosis of gener-
alised joint hypermobility, underlying genetic syndromes,
and complications such as widespread musculoskeletal
pain and chronic fatigue, are largely based on clinical cri-
teria. The genetic causes of joint hypermobility include
Ehlers – Danlos syndromes (EDS), some types of Osteo-
genesis Imperfecta (OI) including types I and IV, Marfan
syndrome and related disorders, and rare HDCT such as
pseudoxanthoma elasticum and cutis laxa syndromes.
Hypermobility may also be a feature of a wide range of
skeletal dysplasia syndromes eg pseudoachondroplasia
and spondyloepiphyseal dysplasia congenita and devel-
opmental syndromes of childhood such as the Fragile-X
syndrome.
Laboratory based genetic tests are available for some of
the more severe types of EDS, OI and Marfan syndrome
and are listed in tables 1, 2 and 3. Currently, confirmatory
laboratory tests for the milder and commonly encoun-
tered HDCT's are not generally available or are prohibi-
tively expensive. Clinical criteria are used to distinguish
between Marfan syndrome (table 1), Ehlers-Danlos syn-
Table 1: Ghent Diagnostic Criteria for Marfan Syndrome – Ho[10].
System Major criteria Minor criteria
Skeletal system Pectus carinatum
Pectus excavatum requiring surgery
Reduced upper to lower segment ratio or arm span to 
height ratio >1.05
Positive wrist and thumb signs
Scoliosis of >20° or spondylolisthesis
Reduced extension of the elbows (<170°)
Medial displacement of the medial malleolus causing pes 
planus
Pectus excavatum of moderate severity
Joint hypermobility
High arched palate with dental crowding
Facial appearance (dolichocephaly, malar hypoplasia, 
enophalmous, retrognathia, and down slanting palpebral 
fissures)
Ocular System Ectopia lentis Abnormally flat corneas
Increased axial length of globe
Hypoplastic iris or cillary muscles causing decreased miosis
Cardiovascular system Dilation of the ascending aorta with or without aortic 
regurgitation and involving the sinuses of valsalva
Dissection of the ascending aorta
Mitral valve prolapse with or without mitral valve 
regurgitation
Dilatation of the main pulmonary artery
Pulmonary system None Spontaneous pneumothorax
Apical blebs (shown on chest radiograph)
Skin and integument Lumbosacral dura ectasia by CT or MRI Stretch marks
Recurrent or incisional herniae
Family history Having a parent, child or sibling with either:
-presence of a mutation in FBN1known to cause Marfans 
syndrome
or
-presence of a haplotype around FBN1, inherited by descent, 
known to be associated with Marfan syndrome in the family.
For the proband the diagnosis requires the presence of major criteria in at least two organ systems and involvement of a third organ system. For a 
family member, diagnosis requires the presence of one major criterion in family history and one major criterion in an organ system and involvement 
of a second organ system.Pediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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Table 2: Diagnostic criteria for Ehlers-Danlos Syndromes – Beighton[9].
Type and Inheritance Major features Minor features Laboratory
Classical
AD
Skin hyperextensibility
Widened atrophic scars
Joint hypermobility
Smooth velvety skin
Molluscoid pseudotumors
Subcutaneous spheroids
Complications of joint hypermobility
(sprains, subluxations/dislocations, 
pes planus)
Muscle hypotonia
Delayed gross motor development
Easy bruising
Manifestations of tissue extensibility 
and fragility†
Postoperative hernia
Positive family history
Abnormalities in skin collagen under 
electron microscopy
Abnormal collagen type V
30% due to mutation in tenascin
Hypermobility
AD
Skin involvement
(hyperextensibility and/or smooth, velvety 
skin)
Generalised joint hypermobility
Recurring joint dislocations
Chronic joint/limb pain
Positive family history
Vascular
AD
Thin, translucent skin
Arterial/intestinal/uterine fragility or 
rupture
Extensive bruising
Characteristic facial appearance
Acrogeria
Hypermobility of small joints
Tendon and muscle rupture
Talipes equinovarus
Early onset varicose veins
Arteriovenous, carotid-cavernous 
sinus fistula
Pneumothorax/
pneumohaemothorax
Gingival recession
Positive family history
Sudden death in close relatives
Abnormal type 3 collagen
COL3A1 mutation
Kyphoscoliotic
AR
Generalised joint laxity
Severe muscle hypotonia at birth
Scoliosis at birth, progressive
Scleral fragility and rupture of the ocular 
globe
Tissue fragility, including atrophic 
scars
Easy bruising
Arterial rupture
Marfan-like habitus
Microcornea
Radiologically considerable 
osteopenia
Family history
Urinalysis for lysylpyridinoline and 
hydroxylysylpyridinoline
Arthrochalasia
AD
Severe generalised joint hypermobility 
with recurrent subluxations
Congenital hip dislocation
Skin hyperextensibility
Tissue fragility, including atrophic 
scars
Easy bruising
Muscle hypotonia
Kyphoscoliosis
Radiologically mild osteopenia
Skin biopsy and demonstration of 
abnormal collagen type 1
Dermatosparaxis
AR
Severe skin fragility
Sagging, redundant skin
Soft doughy skin texture
Easy bruising
Premature rupture of fetal 
membranes
Large hernias 
(inguinal and umbilical)
Demonstration of abnormal collagen 1 
chains in skin
†this included hiatus hernia, anal prolapse, cervical insufficiency for a diagnosis a patient must have one or more of the major criteria and presence 
of minor criteria is "suggestive" of a diagnosis. Items in bold are distinguishing features of that particular subtype of Ehlers-Danlos syndrome.Pediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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drome (table 2) and the milder forms of Osteogenesis
Imperfecta (table 3). The Beighton score, which is the
screening test for joint hypermobility, is incorporated into
the diagnostic criteria for BJHS[8], EDS[9], Marfan[10]
and OI[11]. EDS (hypermobile type) often becomes the
"default" diagnosis if a hypermobile child does not meet
the criteria for diagnosis of one of the other HDCT's and
therefore this is probably a heterogeneous group. Patients
with overlap conditions, for example OI/EDS, have been
reported[12].
It remains unclear why some hypermobile children
become symptomatic while others remain symptom-
free[13]. There is need for a reliable way of identifying
children with joint hypermobility who are at high risk of
developing musculoskeletal complications so that educa-
tion and therapeutic interventions can be targeted to this
group before they become symptomatic or sustain inju-
ries[14,15]. It is also important to accurately identify chil-
dren who are at risk of catastrophic cardiac or vascular
complications later on, for example, children with EDS
(vascular type).
(Benign) Joint Hypermobility Syndrome (BJHS) describes
the combination of joint hypermobility with associated
symptoms such as chronic joint pain, back pain, joint sub-
luxation and dislocations, soft tissue injuries, Marfan syn-
drome-like habitus and skin features. It is diagnosed using
the 1998 Brighton criteria[8] (table 4). The Brighton crite-
ria contain both phenotypic features of HDCTs and symp-
toms which are thought to be complications of joint
Table 3: Disorders predisposing to bone fragility which can be associated with joint hypermobility Munns and Sillence[11].
Type Inheritance Discriminatory 
features
Other features Laboratory
Osteogenesis imperfecta type I AD Blue sclera
Hypermobility, especially 
of small joints
Wormian bones 
(70% of subjects)
Generalised osteopenia on 
DEXA
Kyphoscoliosis
Arcus cornea
Hearing impairment
Metatarsus varus
Easy bruising
Fractures from minimal 
trauma
Opalescent dentine
Reduction in synthesis of type I 
procollagen
Abnormalities in COL1A1
Osteogenesis imperfecta type I 
with opalescent dentine
AD As above with opalescent 
dentine
Osteogenesis imperfecta type IV AD White sclera
Fractures from minimal 
trauma
Short stature
Wormian bones in 50–
70%
Progressive long bone 
deformity
Joint hypermobility
COL1A1 or COL1A2 mutations 
which reduce collagen stability.
Osteogenesis imperfecta type IV 
with opalescent dentine
AD As above with opalescent 
dentine
Geroderma osteodysplasticum AR Osteopenia
Platyspondyly
Learning disability
Joint hypermobility
Skin hyperelasticity
Wormian bones
Items in bold are distinguishing features of that particular subtype of OI
Table 4: The 1998 Brighton criteria for a diagnosis of Benign 
Joint Hypermobility Syndrome[8].
Major Criteria:
1. Beighton Score of ≥ 4/9
2. Arthralgia for > 3 months in > 4 joints
Minor Criteria:
1. Beighton score of 1–3
2. Arthralgia in 1–3 joints
3. History of joint dislocation
4. Soft tissue lesions >3
5. Marfan-like habitus
6. Skin striae, hyperextensibility or scarring
7. Eye signs, lid laxity
8. History of varicose veins, hernia, visceral prolapse
For a diagnosis to be made either both of the major criteria must be 
present or 1 major and 2 minor or 4 minor.Pediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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hypermobility. They exclude children with a diagnosed
HDCT from the diagnosis of (benign) joint hypermobility
syndrome, and this approach is confusing for clinicians. A
standard way of describing a child who has articular and
extra-articular complications of joint hypermobility is
needed irrespective of the underlying genetic diagnosis or
clinical phenotype.
Methods
Medline was searched using a strategy designed by a med-
ical librarian to identify papers on the diagnosis of liga-
mentous laxity, hypermobility, hypermobility syndromes
and related HDCT's (Figure 1). Duplicates were excluded
and titles were hand searched. Papers which focused on
joint stability following joint replacement surgery were
excluded, leaving a total of 3330 papers. The titles of
papers that focused on a single joint were checked to
determine which joints were most frequently the focus of
published works but not further analysed.
The conclusions of this literature analysis were compared
with the experience of The Connective Tissue Dysplasia
(CTD) Clinic, a multidisciplinary clinic established in
1987 at the Children's Hospital at Westmead, Sydney,
Australia to coordinate the care of patient groups with
HDCT.
Search results
In total, 3629 papers were identified, of which 63 (which
were duplicates) and 236 (which related to instability fol-
lowing joint replacement surgery) were excluded, leaving
3330 papers. Of these, 1534 papers focused on laxity of a
specific joint: the majority related to the shoulder, ankle,
spine, knee and TMJ as illustrated in table 5. Most of these
papers describe joint laxity resulting from soft tissue
injury rather than inherited joint laxity.
There were 1666 papers relating to the diagnosis of Ehlers-
Danlos syndromes and a further 330 to joint hypermobil-
ity syndrome(s). The two articles which focus on the
validity of diagnostic criteria are both written by Rem-
vig[5,16] and represent comprehensive reviews of the cur-
rent literature on the diagnostic tests for identifying
generalised joint hypermobility and the criteria for diag-
nosing Benign Joint Hypermobility Syndrome (BJHS).
Definitions of hypermobility, hyperlaxity, hyperextensibility
The words "hypermobility", "hyperlaxity" and "hyperex-
tensibility" are used interchangeably by some authors[17]
and have not been clearly defined. The word "hypermo-
bility" is most commonly used to describe excessive
movement in the normal plane of movement, most fre-
quently hyperextension, and "laxity" is used to describe
excessive movement in an abnormal plane of movement
e.g. inferior subluxation of the shoulder giving an inferior
sulcus sign. However, joints can be hypermobile without
being lax and we believe that whereas laxity is a more
important predictor of instability of any particular joint,
Search strategy Figure 1
Search strategy.
Database: Medline 1966-November week 1 2007. 
Executed 15.11.2007 
Search terms:
1.  Ligamentous lax$.mp (280) 
2.  joint hypermobility.mp (330) 
3. *Joint  Instability/  (5866) 
4.  *Ehlers-Danlos Syndrome/ (1666) 
5. or/1-4  (7795) 
6.  exp Diagnosis/ (4224960) 
7.  5 and 6 (3752) 
8.  limit 8 to humans (3629) 
Table 5: Frequency of joints which are the main focus of papers 
on Ligamentous laxity
Joint Number of papers Frequency %
Temporomandibular joint 30 1.1
Spine 302 12
Shoulder 861 34.3
Elbow 225 9
Wrist 229 9
Hip 229 9
Knee 287 11.4
Patellofemoral joint 19 0.7
Ankle 325 13
Total Single Joint 1534 99.5%
Ehlers-Danlos Syndrome 1666
Joint Hypermobility 330
Total 3330
The totals do not add up to 3330 as 200 papers discussed both 
instability of a single joint and either Ehlers-Danlos syndrome or Joint 
hypermobility syndrome.Pediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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generalised hypermobility, weakness and poor proprio-
ception are better predictors of generalised symptoms
such as widespread arthralgia and fatigue.
The relationship between Benign Joint Hypermobility 
Syndrome and Heritable Disorders of Connective Tissue
The Brighton criteria (table 4) for the diagnosis of BJHS
include phenotypic features eg "Marfanoid Habitus" as
well as symptoms and Remvig argues that use of "Marfan-
like habitus and eye signs in the diagnostic criteria is ques-
tionable". The original Brighton criteria[8] stated that a
diagnosis of BJHS could only be made in the absence of a
diagnosed HDCT. However we find in clinical practice
that patients with HDCTs frequently have widespread
arthralgia and/or disabling fatigue and/or joint instability
episodes and need rehabilitation for these symptoms as
well as genetic and medical management for their under-
lying condition.
Our clinical approach to children presenting with joint
hypermobility is illustrated in figure 2. We work as a team
with clinical geneticists establishing the diagnosis of the
underlying HDCT where possible and the interdiscipli-
nary rehabilitation team identifying and managing related
functional symptoms.
Distinguishing between Ehlers-Danlos syndrome 
(hypermobile type) and "normal spectrum hypermobility"
There is a spectrum of generalised joint hypermobility in
children and the phenomenon is almost certainly poly-
genic in origin with environmental influences, particu-
larly participation in sport and flexibility training.
Younger children are more flexible but this resolves with
increasing age in normal children. It is a clinical challenge
to distinguish young children with significant hypermo-
bility who are unlikely to improve from those who are in
the normal spectrum of hypermobility and will improve
with time. Clinical follow up over several years is currently
the only way of answering this question for an individual
child.
The current criteria for a diagnosis of Ehlers-Danlos syn-
drome (hypermobile type) are illustrated in table 2 but
are non-specific. For a diagnosis to be made an individual
needs to have one of the major criteria of a Beighton score
of ≥ 4/9 or "Skin involvement (hyperextensibility and/or
smooth, velvety skin)". Beighton et al[9] describe testing
of skin hyperextensibility at a neutral site e.g. the volar
aspect of the forearm where "the skin is pulled up until
resistance is felt" but they do not describe a reproducible
measurement which can be taken during this test, nor
what might be normal and abnormal. Minor criteria
which are "of lesser diagnostic specificity" include recur-
rent joint dislocation, chronic joint/limb pain and a posi-
tive family history. The presence of one or more minor
criteria is "suggestive" of the diagnosis. The criteria are
much clearer than in previous classifications for the more
severe subtypes of EDS, but are not specific enough to be
very helpful in distinguishing between EDS (hypermobile
type) and "normal spectrum" hypermobility. We nor-
mally use the diagnosis of Ehlers-Danlos syndrome
(hypermobile type) in patients with one major criteria
and any one of the minor criteria and tend to diagnose
individuals whom we perceive to have very soft skin as
EDS (hypermobile type), although we do not have an
objective measure of skin quality.
We refer all our hypermobile patients with a Beighton
score of ≥ 4/9 for a cardiac and echocardiography assess-
ment to look for mitral valve and aortic root abnormali-
ties. If minor cardiac signs are present we use the EDS
(hypermobile type) diagnosis[18] and consider the diag-
nosis of Marfan syndrome.
Identifying the subgroup who have more muscle involve-
ment e.g. those with tenascin-X deficiency[19], is particu-
larly relevant to rehabilitation management because there
is a subgroup of children who respond poorly to muscle
strengthening interventions and need more intensive
rehabilitation over a longer period to achieve their func-
tional goals. We do not currently test for tenascin-X defi-
ciency in clinical practice.
Distinguishing between Ehlers-Danlos syndrome 
(hypermobile type) and Osteogenesis Imperfecta types I 
and IV and the evaluation of bone health in hypermobile 
children
Children with mild subtypes of Osteogenesis Imperfecta
(OI) are usually of average stature and usually have a his-
tory of minimal trauma fractures. Patients may also have
mid thoracic back pain from vertebral crush fractures. We
have, however, identified family members with OI type I
who have never sustained a fracture (see Appendix 1).
Dark blue sclerae are a distinguishing feature of OI type I
as is opalescent dentine (dentinogenesis imperfecta) and
Wormian bones are highly suggestive but not pathogno-
mic of OI. In one clinical study of 65 patients with OI type
I, 64.6% had hypermobility in the upper limbs and 36.9%
in the lower limbs evidenced by genu recurvatum[20].
Seventy percent of patients with OI type I in this study had
recurrent sprains and dislocations did occur but were
uncommon. Easy bruising was reported in 78% of sub-
jects and was frequently present at interview. Osteogenesis
imperfecta is a disorder of high bone turnover so markers
of bone turnover such as urinary deoxypyridinoline/creat-
inine ratio are frequently elevated.
Children with mild OI have slender bones, increasing
their risk of fracture. Due to decreased bone size, bone
mineral content (BMC) is reduced and there is a reductionPediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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The connective tissue dysplasia clinic diagnostic approach to a child with hypermobile joints Figure 2
The connective tissue dysplasia clinic diagnostic approach to a child with hypermobile joints.
“unspecified” Heritable Disorder of Connective Tissue 
(Re) Consider 
the underlying 
Genetic
Diagnosis 
Disabling
Fatigue Osteopenia 
Ophthalmology
Assessment
Marfan Syndrome
Loeys –Dietz 
Hypermobile child 
Beighton  4/9 
Widespread
musculoskeletal
pain
Cardiology 
review with 
echocardiogram
Check for functional 
symptoms of “joint 
hypermobility syndrome” 
and formulate a 
management plan
Joint
instability
episodes
Ehlers Danlos 
Syndromes
Assessment of 
bone health 
Osteogenesis
imperfecta
Review clinical 
progress and 
evolution of 
phenotype
Annually to 
biannually
Soft
tissue
injuries
AnxietyPediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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in the BMC for lean tissue mass ratio, reflecting the pri-
mary nature of the bone pathology. Dual energy x-ray
absorbtiometry (DXA) can be used to measure these
parameters but accurate interpretation depends on the
availability of age matched standards. Another useful and
accessible tool for assessing bone phenotype is the com-
parison of the cortical diameter of the 2nd metacarpal
bone to normal values[21].
Patients with generalised joint hypermobility have been
shown to be at risk of osteopenia in several studies[17,22-
24] so it is worthwhile evaluating bone health in all
hypermobile children. Gulbar[23] demonstrated a corre-
lation between increasing Beighton score and decreasing
bone density at the hip, measured by DEXA, in a small
case-control study of hypermobile adult women after con-
trolling for confounders such as smoking and physical
activity. The osteopenia is most likely to be a result of
muscle weakness and lack of constraint to joint move-
ment, which decrease the forces transmitted to the bone.
It is possible that some undiagnosed OI patients were
included in some of the above studies, affecting the
results. We recommend investigating all patients with a
significant fracture history, blue sclera and/or Dentino-
genesis Imperfecta for Osteogenesis Imperfecta and also
evaluate bone health in children with a Beighton score of
≥ 4/9 using the investigations listed in Appendix 2.
Distinguishing between Ehlers-Danlos (Hypermobile type) 
and Marfan syndrome and related disorders
Marfan syndrome is well described and the available algo-
rithm for diagnosis (table 1) is based on the clinical fea-
tures. The reliability and validity of the Ghent criteria has
not been established. Marfan syndrome is caused by
mutations in the FBN1 gene which codes fibrillin, a struc-
tural protein present in microfibrils and a key component
of connective tissue. In a recent cohort study of patients
with a laboratory confirmed FBN1 mutation, 600/956
(63%) had "ligamentous laxity", which was the third
commonest major skeletal feature after arachnodactyly
and high arched palate[25]. Clinically, we have found that
some hypermobile patients with a "Marfan-like" habitus
do not meet the criteria for a formal diagnosis of Marfan
syndrome. It is wise to be cognisant of the fact that the
phenotype will evolve with time and that finding a FBN1
mutation in a child with major skeletal features would
support a diagnosis. For example, a child with pes planus
and mitral valve prolapse would meet the criteria for a
diagnosis of Marfan syndrome if a FBN1 mutation was
found on testing. Children who have a mutation but do
not meet the Ghent criteria are described as having a type
1 fibrillinopathy. There is an increased incidence of Mar-
fan-like habitus in some hypermobile populations[7] but
the influence of this feature on the risk of complications
of hypermobility is unclear.
Marfan syndrome can be complicated by chronic wide-
spread musculoskeletal pain and fatigue and patients with
Marfan syndrome may also meet the diagnostic criteria for
(benign) Joint Hypermobility Syndrome and/or chronic
fatigue syndrome. The latter group of patients may have
very disabling symptoms and a similar rehabilitation
approach to that used for other hypermobile children can
be used, tempered in its intensity by the patient's cardio-
vascular involvement. Using a diagnosis of Joint Hyper-
mobility Syndrome in symptomatic patients with Marfan
syndrome aids in defining and understanding a particular
patient's needs.
Vascular involvement – Ehlers Danlos Syndrome (Vascular 
type) or Loeys-Dietz Syndrome?
There are subgroups of children who present with hyper-
mobility and who are at significant risk of mortality as a
result of vascular fragility in early adulthood. These chil-
dren have hypermobility, particularly of small joints, thin
translucent skin, lack of subcutaneous fat and bruise eas-
ily. They are prone to complications including aortic dis-
section, stroke from ruptured cerebral vessels and uterine
and bowel rupture. There may be a family history of sud-
den death. EDS (vascular type) is due to a defect in
COL3A1 therefore a diagnosis can be made if mutations
are found in the type III collagen gene.
As with the other HDCTs phenotypic overlap exists
between EDS (vascular type) and another disorder, Loeys-
Dietz syndrome. This is a recently described autosomal
dominant syndrome characterised by arterial tortuosity,
hypertelorism and bifid uvula or cleft palate. It is caused
by mutations in the transforming growth factor beta
receptor genes (TGFBR1 and 2). The disorder is character-
ised by arterial aneurysms and mean age of death in a
recent cohort was 26 years[26]. The authors comment that
one way of distinguishing between the two diagnoses is
the lower rate of intraoperative mortality in Loeys-Dietz
syndrome – not an ideal diagnostic test. As this syndrome
has been described so recently the cases identified have
been those presenting with complications. Mildly affected
relatives who have been identified as having the genetic
mutation after families have been screened may present
with isolated hypermobility, especially in childhood[26].
Conclusion
We describe our approach to the diagnosis of a child who
presents with hypermobility and related symptoms. It is
important to consider the child's underlying genetic diag-
nosis as well as to accurately describe their functional
symptoms. This results in some children having two diag-
noses – one of their HDCT and another describing func-
tional complications. As the field of genetics moves
forward we will be able to more accurately diagnose the
genetic disorder underlying an individual child's hyper-Pediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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mobility and the relevance of subtle phenotypic features
in the mild HDCT will become clearer.
We believe that the "benign" descriptor in "benign joint
hypermobility syndrome" is misleading and unhelpful and
prefer "Joint Hypermobility Syndrome" to describe the
combination of generalised joint hypermobility and func-
tional symptoms. Consideration needs to be given to limit-
ing diagnostic criteria to symptoms only rather than
including a mixture of phenotypic features which are prob-
ably more relevant to the underlying genetic diagnosis.
Most authors now agree that children diagnosed as having
Ehlers-Danlos syndrome (hypermobile type) or (benign)
joint hypermobility syndrome represent the mild end of
the spectrum of heritable disorders of connective tissue.
Current research using this group is challenging because
there is significant variability between individuals in this
ill-defined population and some have features which
overlap diagnostic groups. There is a need for descriptive
studies of large cohorts of individuals with joint hypermo-
bility to investigate the relationship between baseline
clinical characteristics and adverse outcomes. In our expe-
rience this condition can have a significant negative
impact on an affected child's ability to function and par-
ticipate in society and is much more disabling than gener-
ally recognised. Accurate diagnosis of Joint Hypermobility
Syndrome facilitates early referral to an interdisciplinary
team with appropriate clinical expertise in its manage-
ment and avoids the use of ineffective measures, in partic-
ular the over prescription of analgesia.
It is important to recognise and manage functional symp-
toms in all children with Heritable Disorders of Connec-
tive Tissue.
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Appendix 1
Case study – AM
AM is an 11 yr old girl who presented with joint hypermo-
bility (Beighton score 7/9) and instability episodes. She
was initially diagnosed as having Ehlers-Danlos Syn-
drome (hypermobile type). She has dark blue sclera and a
family but not a personal history of low trauma fractures.
Osteopenia compared to age matched controls was
present on DEXA so her diagnosis was revised to Osteo-
genesis Imperfecta type 1.
AM's current clinical problems include:
￿ recurrent dislocation of the right 4th metacarpophalyn-
geal joint
￿ painful toe subluxations
￿ longstanding anterior knee pain worse after activity
￿ handwriting difficulties
Although OI is her genetic diagnosis, her symptoms and
functional problems relate to her Joint hypermobility and
management needs to be focused on these areas. She
would meet the Brighton criteria for a diagnosis of benign
joint hypermobility syndrome but is excluded from this
group as she has mild OI. Her management ideally should
include multidisciplinary musculoskeletal rehabilitation.
Appendix 2
Assessment of bone health in hypermobile children
Blood tests:
￿ Urea and Electrolytes
￿ Calcium magnesium and phosphate
￿ Alkaline phosphatase
￿ Parathyroid Hormone
￿ Full blood count and ESR
￿ Osteocalcin
￿ Vitamin D (25 hydroxyvitamin D)
￿ Thyroid Stimulating Hormone
￿ Oestradiol
￿ Testosterone
￿ Antitissue Transglutaminase antibodies
￿ Immunoglobulin A
Urine Tests
￿ Random urine creatinine
￿ Random urine CA:CR ratioPediatric Rheumatology 2009, 7:1 http://www.ped-rheum.com/content/7/1/1
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￿ Deoxypyridinoline and Deoxypyridinoline:CR ratio
￿ Urine metabolic screen
DEXA scan for Bone Mineral Density
Additional investigations to look for Osteogenesis 
Imperfecta
Evaluation of cortical thickness from anteroposterior
hand and wrist ("bone age") radiographs
1. measure total bone diameter of second metacarpal on
the right hand at the midpoint of the bone
2. measure trabecular bone diameter
3. calculate ratio
4. compare to normal values for age and sex as published
in Spencer et al
Skull X-ray to look for Wormian Bones (more than 10
which are of greater than 4 × 6 mm in size).
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